Development and Validation of a Predictive Model for Metastatic Melanoma Patients Treated with Pembrolizumab Based on Automated Analysis of Whole-Body [(18)F]FDG PET/CT Imaging and Clinical Features

SIMPLE SUMMARY: Blockade of the programmed cell death protein 1 (PD-1) receptor is an established standard-of-care treatment option that significantly improves survival of patients with advanced melanoma. While a smaller proportion of the population can derive a durable remission (even cure), most p...

Descripción completa

Detalles Bibliográficos
Autores principales: Dirks, Ine, Keyaerts, Marleen, Dirven, Iris, Neyns, Bart, Vandemeulebroucke, Jef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452475/
https://www.ncbi.nlm.nih.gov/pubmed/37627111
http://dx.doi.org/10.3390/cancers15164083

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452475/
https://www.ncbi.nlm.nih.gov/pubmed/37627111
http://dx.doi.org/10.3390/cancers15164083

Ejemplares similares